• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There aren't many studies regarding how exposure over time may affect a foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to weigh the benefits of taking it against the possible risks for the foetus. Physicians do not have the necessary data to make unequivocal recommendations, but they can provide information regarding risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy were not at greater risk of fetal malformations, or structural birth defects. The researchers used a large population-based study of case-control to evaluate the incidence of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy, and those who did not. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure correct classification of the cases and to reduce the possibility of bias.

The research conducted by the researchers was not without limitations. The researchers were not able to, in the first place to distinguish the effects caused by the medication from the disorder. This makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to medication use or if they were caused by the presence of comorbidities. Researchers also did not examine long-term outcomes for offspring.

The study did reveal that infants whose mothers had taken ADHD medications during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or had stopped their medications before or during pregnancy. This increase was due to central nervous system-related disorders and the higher risk of admission was not found to be influenced by which stimulant medications were taken during pregnancy.

Women who used stimulant ADHD medication for adhd and odd during pregnancy also had an increased risk of having a caesarean delivery or having a child with low Apgar score (less than 7). These increases did not appear to be affected by the type of medication that was used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both the mother and child of continued treatment for the woman's condition. Physicians should speak with their patients about this and as much as possible, assist them improve coping skills Which Adhd Medication Is best adhd medication for adults with anxiety and depression For Me Quiz (Psychiatry84902.Mybuzzblog.Com) can lessen the impact of her disorder in her daily life and relationships.

Interactions with Medication

As more women than ever are being diagnosed with ADHD and being treated with medication, the issue of whether to continue or discontinue treatment during pregnancy is one that more and more physicians confront. These decisions are frequently made without clear and reliable evidence. Instead, doctors have to consider their own expertise and experience, as well as the experiences of other doctors and the research that has been conducted on the subject.

The issue of possible risks to the infant can be particularly tricky. Many studies on this subject are based on observational data instead of controlled research and their findings are often contradictory. The majority of studies limit their analysis to live births, which can underestimate the teratogenic impact that can lead to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these shortcomings, by examining both the data from deceased and live births.

The conclusion: While some studies have shown a positive association between ADHD medications and the risk of certain birth defects, others have not found any evidence of a link, and most studies have a neutral or slightly negative impact. In the end, a careful risk/benefit analysis must be done in each instance.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. Additionally, the loss of medication may affect the ability to complete jobs and drive safely which are essential aspects of a normal life for many people suffering from ADHD.

She recommends women who are uncertain about whether or not to stop taking medication because of their pregnancy consider educating family members, friends and colleagues on the condition, its impact on daily life, and the advantages of staying on the current treatment regimen. In addition, educating them can make the woman feel more comfortable in her struggle with her decision. Certain medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the drug may be transferred to her infant.

Birth Defects Risk

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns about the effects that the drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this topic. Researchers utilized two massive datasets to analyze over 4.3 million pregnancy and determine if stimulant medication use increased birth defects. Researchers found that while the overall risk is low, first-trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, like ventriculoseptal defect.

The researchers behind the study found no link between early use of medication and other congenital abnormalities, such as facial clefting or club foot. The results are in the same vein as previous studies which showed the existence of a slight, but significant increase in the number of cardiac malformations among women who began taking ADHD medication prior to the time of pregnancy. This risk increased during the latter part of pregnancy, as many women begin to discontinue their medication.

Women who took does adhd medication work medication in the first trimester of their pregnancies were also more likely to have caesarean sections, a low Apgar score following delivery, and a baby who needed breathing assistance at birth. The researchers of the study could not eliminate bias due to selection because they restricted the study to women with no other medical conditions that could have contributed to the findings.

The researchers hope their study will serve to inform the clinical decisions of physicians who see pregnant women. They suggest that although discussing the benefits and risks is important but the decision to stop or keep treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors caution that, while stopping the medication is a possibility to look into, it is not advised due to the high prevalence of depression and other mental problems for women who are pregnant or who have recently given birth. Further, research shows that women who stop taking their medications will have a tough adjustment to life without them once the baby is born.

Nursing

It can be overwhelming becoming a mother. Women who suffer from ADHD who have to deal with their symptoms while attending doctor appointments as well as preparing for the arrival of a baby and adjusting to new household routines may face a lot of challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medications passes through breast milk at low levels. However, the frequency of exposure to medications by the infant can differ based on dosage, frequency it is administered, and at what time the medication is administered. In addition, various medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The impact of these medications on the health of a newborn isn't fully known.

Because of the lack of research, some physicians may recommend stopping stimulant medications during the course of pregnancy. This is a complicated decision for the patient, who must weigh the benefits of continuing her medication with the potential dangers to the fetus. As long as more information is available, GPs may ask pregnant patients if they have an background of ADHD or if they are planning to take medication during the perinatal period.

A increasing number of studies have proven that most women can safely continue their ADHD medication during pregnancy and while breastfeeding. This has led to an increasing number of patients are choosing to do so, and in consultation with their physician, they have found that the benefits of keeping their current medication exceed any risk.

It is essential for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of their symptoms and the root cause and learn about treatment options and strengthen existing strategies for coping. This should be a multidisciplinary approach including obstetricians, GPs, and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, and monitoring for signs of deterioration, and, if needed modifications to the medication regimen.